Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals
Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals
预测未来：11位分析师对Crinetics药品的预测
Throughout the last three months, 11 analysts have evaluated Crinetics Pharmaceuticals (NASDAQ:CRNX), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，11位分析师评估了Crinetics药品（纳斯达克：CRNX），提出了从看好到看淡的多样化意见。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下表展示了过去30天内不断变化的情绪，并将其与之前的几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $69.82, a high estimate of $97.00, and a low estimate of $60.00. This current average has increased by 13.27% from the previous average price target of $61.64.
由分析师分析的12个月价格目标提供了一些见解，平均目标为69.82美元，最高估计达到97.00美元，最低估计为60.00美元。这个当前平均值比上一个61.64美元的平均价格目标增长了13.27%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
The analysis of recent analyst actions sheds light on the perception of Crinetics Pharmaceuticals...
最近的分析师行动分析揭示了金...
登录免费看全文
登录/注册